Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 2
R&D Momentum
73/100
Pipeline Velocity
45/100
Trial Completion Rate
87/100
Pipeline Concentration
50/100
Pipeline Freshness
54/100
Strategic Signals
Activity
Last 14 days
Identifying Markers of Disease Subtypes and Disease Progression in the Syndrome of Essential Tremor - a Prospective Cohort Study
Measurement Agreement Between Intraarterial (IBP) and Intermittent Non-Invasive Blood Pressure (NIBP) Monitoring During Induction of Anesthesia in High Risk Patients: The AGREE-BP Prospective Observational Study
An Explorative Prospective Non-interventional Study on Sedation Depth in Postoperative Cardiac Surgery Patients Using Blinded BIS Monitoring
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)